Simplification from protease inhibitors to once-or twice-daily raltegravir: The ODIS trial

  1. Vispo, E.
  2. Barreiro, P.
  3. Maida, I.
  4. Mena, A.
  5. Blanco, F.
  6. Rodríguez-Novoa, S.
  7. Morello, J.
  8. Jimenez-Nacher, I.
  9. Gonzalez-Lahoz, J.
  10. Soriano, V.
Journal:
HIV Clinical Trials

ISSN: 1528-4336

Year of publication: 2010

Volume: 11

Issue: 4

Pages: 197-204

Type: Article

DOI: 10.1310/HCT1104-197 GOOGLE SCHOLAR

Sustainable development goals